Cataract drugs in development, 2023

GlobalData tracks 19 drugs in development for Cataract by 17 companies/universities/institutes. The top development phase for Cataract is preclinical, with 13 drugs in that stage.

GLP-1R market: a two-horse race – Pharmaceutical Technology

Glucagon-like peptide-1 receptor (GLP-1R) products [a class of incretin mimetic medicines for the treatment of type 2 diabetes and obesity] generated more than $37 billion

August 20, 2024

DOUGLAS Group raises sales forecast for the financial year 2023/24 and sells online pharmacy Disapo – Biotech Investments

EQS-News: Douglas AG / Key word(s): Development of Sales DOUGLAS Group raises sales forecast for the financial year 2023/24 and sells online pharmacy Disapo 17.07.2024

July 18, 2024

Dexcom receives FDA clearance for first OTC glucose sensor

Dive Brief: Dexcom has received clearance for the first over-the-counter (OTC) glucose sensor in the U.S. The Food and Drug Administration cleared the device, Stelo,

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.